Healthcare provider profile · identity verified

Bernard R Quebral, MD

Internal Medicine · WOODBURY, MN · NPI 1235100892

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	924	265
Amlodipine Besylate	Amlodipine Besylate	628	173
Losartan Potassium	Losartan Potassium	596	167
Levothyroxine Sodium	Levothyroxine Sodium	351	96
Metoprolol Succinate	Metoprolol Succinate	346	96
Omeprazole	Omeprazole	319	106
Jardiance	Empagliflozin	314	88
Metformin Hcl	Metformin Hcl	300	88
Simvastatin	Simvastatin	273	74
Lisinopril	Lisinopril	256	74
Gabapentin	Gabapentin	195	66
Tamsulosin Hcl	Tamsulosin Hcl	193	59
Rosuvastatin Calcium	Rosuvastatin Calcium	190	59
Allopurinol	Allopurinol	159	43
Sertraline Hcl	Sertraline Hcl	159	43
Furosemide	Furosemide	158	54
Fluticasone Propionate	Fluticasone Propionate	148	63
Metformin Hcl Er	Metformin Hcl	144	44
Hydrochlorothiazide	Hydrochlorothiazide	140	40
Warfarin Sodium	Warfarin Sodium	129	21
Trazodone Hcl	Trazodone Hcl	109	36
Atenolol	Atenolol	101	30
Xarelto	Rivaroxaban	101	29
Potassium Chloride	Potassium Chloride	99	31
Trulicity	Dulaglutide	94	21
Chlorthalidone	Chlorthalidone	93	33
Eliquis	Apixaban	92	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	92	26
Albuterol Sulfate Hfa	Albuterol Sulfate	91	41
Alendronate Sodium	Alendronate Sodium	86	25
Finasteride	Finasteride	85	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	85	26
Mounjaro	Tirzepatide	83	19
Metoprolol Tartrate	Metoprolol Tartrate	74	23
Duloxetine Hcl	Duloxetine Hcl	73	24
Carvedilol	Carvedilol	70	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	17
Prednisone	Prednisone	68	42
Ezetimibe	Ezetimibe	66	25
Azelastine Hcl	Azelastine Hcl	62	24
Pantoprazole Sodium	Pantoprazole Sodium	62	18
Nitroglycerin	Nitroglycerin	61	37
Triamcinolone Acetonide	Triamcinolone Acetonide	60	36
Pravastatin Sodium	Pravastatin Sodium	56	15
Hydroxyzine Hcl	Hydroxyzine Hcl	55	19
Tizanidine Hcl	Tizanidine Hcl	55	26
Celecoxib	Celecoxib	54	15
Montelukast Sodium	Montelukast Sodium	53	16
Glipizide Er	Glipizide	52	16
Ropinirole Hcl	Ropinirole Hcl	52	16
Doxepin Hcl	Doxepin Hcl	51	20
Clopidogrel	Clopidogrel Bisulfate	50	15
Famotidine	Famotidine	50	15
Diclofenac Sodium	Diclofenac Sodium	48	33
Citalopram Hbr	Citalopram Hydrobromide	47	14
Spironolactone	Spironolactone	46	14
Pregabalin	Pregabalin	42	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	30
Zolpidem Tartrate	Zolpidem Tartrate	40	14
Alfuzosin Hcl Er	Alfuzosin Hcl	37	12
Naproxen	Naproxen	37	21
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Latanoprost	Latanoprost	34	suppressed
Methocarbamol	Methocarbamol	34	15
Glipizide	Glipizide	33	13
Klor-Con M20	Potassium Chloride	33	12
Farxiga	Dapagliflozin Propanediol	32	suppressed
Mirtazapine	Mirtazapine	32	12
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Rybelsus	Semaglutide	32	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Ketoconazole	Ketoconazole	29	19
Doxycycline Monohydrate	Doxycycline Monohydrate	26	17
Fluocinonide	Fluocinonide	25	11
Ibuprofen	Ibuprofen	25	suppressed
Risperidone	Risperidone	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Ozempic	Semaglutide	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	17
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Irbesartan	Irbesartan	19	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	18	suppressed
Febuxostat	Febuxostat	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Hydrocortisone	Hydrocortisone	18	14
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Cephalexin	Cephalexin	16	14
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Calcitriol	Calcitriol	15	suppressed
Colchicine	Colchicine	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Invokana	Canagliflozin	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Epinephrine	Epinephrine	14	13
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Azithromycin	Azithromycin	13	12
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Rhopressa	Netarsudil Mesylate	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Nystatin	Nystatin	11	suppressed
Nystop	Nystatin	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Ursodiol	Ursodiol	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error